FlexBioTech Overview
- Year Founded
-
2016
- Status
-
Private
- Latest Deal Type
-
Later Stage VC
- (In Progress)
- Latest Deal Amount
-
$1.5M
- Investors
-
3
FlexBioTech General Information
Description
Operator of a molecular diagnostic company intended to replace centralized clinical laboratory testing with disposable, rapid-result, and point-of-care diagnostic testing. The company offers biomarker-based assay development and medical diagnostic electronic instruments, enabling clinicians with a saliva-based test that uses proprietary deoxyribonucleic acid and ribonucleic acid biomarkers and a low-cost, portable system to diagnose diseases.
Contact Information
Website
www.flexbiotech.comCorporate Office
- 275 North Gateway Drive
- Suite 106
- Phoenix, AZ 85034
- United States
Corporate Office
- 275 North Gateway Drive
- Suite 106
- Phoenix, AZ 85034
- United States
FlexBioTech Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Later Stage VC | $1.5M | In Progress | Generating Revenue | |||
| 3. Grant | 01-Jan-2025 | Completed | Generating Revenue | |||
| 2. Grant | 01-Dec-2021 | $5K | Completed | Generating Revenue | ||
| 1. Grant | 25-May-2017 | $750.00 | Completed | Startup |
FlexBioTech Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| National Cancer Institute | Government | |||
| Ira A. Fulton Schools of Engineering | Accelerator/Incubator | |||
| ISCAS 2017 | Other |
FlexBioTech FAQs
-
When was FlexBioTech founded?
FlexBioTech was founded in 2016.
-
Where is FlexBioTech headquartered?
FlexBioTech is headquartered in Phoenix, AZ.
-
What industry is FlexBioTech in?
FlexBioTech’s primary industry is Diagnostic Equipment.
-
Is FlexBioTech a private or public company?
FlexBioTech is a Private company.
-
What is FlexBioTech’s current revenue?
The current revenue for FlexBioTech is .
-
Who are FlexBioTech’s investors?
National Cancer Institute, Ira A. Fulton Schools of Engineering, and ISCAS 2017 have invested in FlexBioTech.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process